|
|
|
By Matthew Featherstone and Rowan Saada, Charles River Associates’ Life Sciences Practice | While AI may soon transform the drug discovery and development process, there are still several barriers, both technical and ethical, to the rise of AI in biopharma. |
|
|
|
|
|
| Mitigating Hidden Risks: Extractables And Leachables | Case Study | By Christopher Wittum, Cambrex | Everything from glass or plastic bottles to the ink used in labels can leach unwanted contaminants. The first challenge chemists address is to narrow the focus onto the most likely suspects. |
|
|
| Complex Molecules, Complex Problems | Article | By Charles Johnson, Lonza | The support of an experienced CDMO is critical to overcoming complexity when working with a highly potent active pharmaceutical ingredient (HPAPI) and when solving solubility challenges. |
|
|
| From Nanoformed Powder To 3D Printable Ink | Poster | By Martti Kaasalainen, Katariina Kojo, Niklas Sandler, and Satu Lakio, et al., Nanoform | 3D printing in pharmaceutics is advancing to offer innovative drug delivery applications. Explore the possibilities of forming stable suspension in printing ink from nanoformed materials. |
|
|
| Approaches To Establishing A Perfusion Mimic Process | Application Note | Sartorius | We demonstrate how high throughput perfusion mimic processes can be achieved in microbioreactors with good consistency amongst the replicates and with sustained cell viability and protein production. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|